Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2017

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Show Description +

Richard B. Rosen, MD, DSc(Hon), describes his talk at ASRS in which he spoke about the use of a normative database to look at perfusion density mapping as a way of understanding the extent of nonperfusion in patients with diabetes. Referencing a mapping system he developed, Dr. Rosen explains the difference between perfusion deviation mapping and perfusion density mapping and the role of optical coherence tomography angiography in judging the extent and abnormality of an individual patient when looking at their perfusion density.

Posted: 8/09/2017

Keywords:

Diabetes

•

perfusion density mapping

Up Next

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Digitally Assisted Vitreoretinal Surgery

Digitally Assisted Vitreoretinal Surgery

Marco Mura, MD

Novel Technique for Steroid Injection

Novel Technique for Steroid Injection

Michael Singer, MD

Treatments for VMT

Treatments for VMT

Nathan C. Steinle, MD

Remaining Cost Effective with 'Slurry' Kenalog

Remaining Cost Effective with 'Slurry' Kenalog

Susan M. Malinowski, MD

Novel Technique for Visual Recovery Testing

Novel Technique for Visual Recovery Testing

John B. Miller, MD

Real-World Outcomes of Anti-VEGF Therapy in DME

Real-World Outcomes of Anti-VEGF Therapy in DME

Thomas A. Ciulla, MD, MBA

Intraoperative OCT in Subretinal Therapeutic Delivery

Intraoperative OCT in Subretinal Therapeutic Delivery

Lejla Vajzovic, MD

Cytogenetics in Uveal Melanoma

Cytogenetics in Uveal Melanoma

Carol Shields, MD

Revisiting VISTA: Nonperfusion and Aflibercept

Revisiting VISTA: Nonperfusion and Aflibercept

Charles Wykoff, MD, PhD

Açai-based Surgical Dye

Açai-based Surgical Dye

Mauricio Maia, MD, PhD

DEL MAR: Phase 2, Stage 2

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Back to All Videos

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Richard B. Rosen, MD, DSc(Hon), describes his talk at ASRS in which he spoke about the use of a normative database to look at perfusion density mapping as a way of understanding the extent of nonperfusion in patients with diabetes. Referencing a mapping system he developed, Dr. Rosen explains the difference between perfusion deviation mapping and perfusion density mapping and the role of optical coherence tomography angiography in judging the extent and abnormality of an individual patient when looking at their perfusion density.

Posted: 8/09/2017

Keywords:

Diabetes

•

perfusion density mapping

Please log in to leave a comment.

More From ASRS: 2017 Coverage

DEL MAR: Phase 2, Stage 2

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Digitally Assisted Vitreoretinal Surgery

Digitally Assisted Vitreoretinal Surgery

Marco Mura, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2017.